ANPEP and hepatocellular carcinoma: In the CD13+-enriched HCC tumor fraction obtained from 5-FU-treated mice serially implanted into secondary animals, tumor development was not found in bestatin-treated mice (n = 0/6), although 60% of untreated mice developed tumors (n = 6/10) [67].